NFU1P2

Across TCGA pan-cancer cohorts, NFU1P2 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated NFU1P2 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher NFU1P2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated NFU1P2 expression acts as an unfavorable survival marker.

LUAD, DLBC, and BLCA are the cancer types where NFU1P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.429	0.676	<.001	114	view →
DLBC	OS	Tertile	II,III,IV	0.099	0.731	.005	90	view →
BLCA	OS	Tertile	IV	0.233	0.601	<.001	54	view →
STAD	OS	Tertile	All	0.266	0.739	<.001	54	view →
MESO	OS	Tertile	All	0.126	0.564	<.001	36	view →
HNSC	DFS	Tertile	All	0.327	0.608	.039	27	view →
PAAD	DFS	Tertile	II,III,IV	0.152	0.442	.001	18	view →
ACC	OS	Tertile	All	0.118	0.624	.038	18	view →
UCEC	OS	Tertile	All	0.825	0.927	.024	18	view →
LIHC	OS	Tertile	All	0.156	0.783	.002	9	view →
KIRC	OS	Tertile	II,III,IV	0.204	0.536	.011	6	view →
BRCA	OS	Tertile	All	0.190	0.579	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

NFU1P2–LUAD (DFS)

Open the LUAD breakdown →